Business Context and Reporting Period
Company: Protagonist Therapeutics, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 14, 2016
Reporting Period: Third quarter ended September 30, 2016
This filing serves as a notification that the company reported its financial results for the three months ended September 30, 2016. The detailed results are contained in a press release furnished as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. These figures are referenced as being available in the attached press release (Exhibit 99.1) but are not present in the source text provided.
Material Changes
The filing text does not provide specific details on material changes versus the prior comparable period. It only confirms the reporting of third-quarter 2016 results.
Guidance, Outlook, and Risks
The filing references a press release titled "Protagonist Therapeutics Reports Third Quarter 2016 Financial Results and Provides Corporate Update." While the title suggests the inclusion of a corporate update, the specific content regarding guidance, outlook, management commentary, risks, or unusual items is not included in the text of this Form 8-K.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q3 2016 revenue, net loss, and cash position figures.
- Verify the "Corporate Update" section in the press release for any changes in clinical trial timelines or strategic direction.
- Confirm the company's cash runway and any recent financing activities mentioned in the full press release.
- Check for any forward-looking statements or guidance updates regarding future quarters.